Plasma soluble Fas ligand concentration: Decrease in elderly men and increase in patients with gastric carcinoma

Oncology Reports

Volumn 8, Issue 2, 2001, Pages 311-314

  Takashiichikura, I ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE HOSPITAL   (Japan)

Author keywords

Age; Gastric cancer; Gender; Plasma; Soluble Fas ligand

Indexed keywords

FAS ANTIGEN; FAS LIGAND; FASLG PROTEIN, HUMAN; MEMBRANE PROTEIN; TUMOR MARKER;

ADULT; AGE; AGING; ARTICLE; BLOOD; CANCER STAGING; COMPARATIVE STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOLOGY; MALE; MIDDLE AGED; PATHOLOGY; REFERENCE VALUE; SEXUAL DEVELOPMENT; STOMACH TUMOR;

ADULT; AGE FACTORS; AGING; ANTIGENS, CD95; ENZYME-LINKED IMMUNOSORBENT ASSAY; FAS LIGAND PROTEIN; FEMALE; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; NEOPLASM STAGING; REFERENCE VALUES; SEX CHARACTERISTICS; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0035289629     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (2)

1. Tanaka M, Suda T, Haze K, Nakamura N, Sato K, Kimura F, Motoyoshi K, Mizuki M, Tagawa S, Ohga S, Hatake K, Drummond AH and Nagata S: Fas ligand in human serum. Nat Med 2: 317-322, 1996.
2. Hasegawa D, Kojima S, Tatsumi E, Hayakawa A, Kosaka Y, Nakamura H, Sako M, Osugi Y, Nagata S and Sano K: Elevation of the serum Fas ligand in patients with hemophagocytic syndrome and Diamond-Blackfan anemia. Blood 91: 2793-2799, 1998.